OBIO
Orchestra BioMedDNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
Positive clinical data and a strategic partnership materially de-risks the growth path, supporting ~+30% upside vs the anchor close.
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Clinical misses, delayed regulatory progress, or dilutive financing could compress value by >25%, reflecting small-cap binary risk.
Momentum
43
Value
36
Sentiment
52
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $4.40 · Bull $5.72 · Bear $3.30
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2025-12-07 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $13.43
Why
Momentum43 · Δ7d -
Value36 · Δ7d -0.0
Sentiment52 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Sentiment · See AI snapshot
Momentum
43
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
36
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
52
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 42.9 / Value 36.4 / Sentiment 52.5
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$234.13M
Beta
0.61
Shares Out
56.46M
P/E (TTM) · Derived
-2.5
P/S (TTM)
84.96
P/FCF (TTM) · Derived
-2.82
Rev YoY
-12.8%
EPS YoY
+2.7%
Gross Margin
+93.0%
Op Margin
-2669.9%
Net Debt
-$52.52M
Current Ratio
4.73
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology